Related Experiment Videos
[The influence of antihypertensive treatment on progression of chronic nepropathy]
L J Petersen1, S D Ladefoged, H A Jensen
1Nefrologisk afdeling, H:S Hvidovre Hospital.
Ugeskrift for Laeger
|July 28, 1997
Abstract:
This article describes the influence of antihypertensive treatment on the kidneys, both the acute and the long-term effects, especially with regard to the progression of chronic non-diabetic renal failure. Our knowledge about the different antihypertensive drugs is still limited, but some studies indicate that especially ACE-inhibition and perhaps calcium antagonism may have the potential to postpone renal failure.
Insights
Antihypertensive treatments impact kidney function acutely and long-term. ACE-inhibition and calcium antagonism may help slow chronic kidney disease progression in non-diabetic patients.
Area of Science:
- Nephrology
- Pharmacology
Context:
- Chronic kidney disease (CKD) progression is a significant concern.
- Understanding the renal effects of antihypertensive medications is crucial for patient management.
Purpose:
- To review the acute and long-term effects of antihypertensive treatments on kidney function.
- To evaluate the potential of specific drug classes in delaying the progression of non-diabetic chronic renal failure.
Summary:
- Antihypertensive therapies exert varied influences on renal health.
- Evidence suggests angiotensin-converting enzyme (ACE) inhibitors and potentially calcium channel blockers may offer renoprotective benefits, delaying renal failure.
- Further research is needed to fully elucidate the long-term renal outcomes associated with different antihypertensive agents.
Impact:
- Provides insights into optimizing antihypertensive strategies for kidney protection.
- Highlights the potential role of ACE inhibitors and calcium antagonists in managing non-diabetic CKD.
- Informs clinical decision-making regarding medication choices for patients with renal impairment.